|Articles|August 5, 2014
Venn Life Sciences Acquires French CRO
Venn Life Sciences announced the acquisition of Cardinal Systems SAS
Advertisement
Venn Life Sciences, a CRO based in Europe, announced the acquisition of Cardinal Systems SAS, a France based CRO specializing in data management and randomization systems. The acquisition extends Venn’s service offering into those two areas, and strengthens the company’s position as a full-service European CRO.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
2
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
3
SCOPE Summit 2026: Reducing Patient Burden Is the Foundation of Wearable Success in Oncology
4
SCOPE Summit 2026: Elevating Patient Experience in Clinical Operations
5